Enzo Biochem, Inc. (ENZ) financial statements (2022 and earlier)

Company profile

Business Address 60 EXECUTIVE BLVD
FARMINGDALE, NY 11735
State of Incorp. NY
Fiscal Year End July 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2022
TTM
7/31/2021
7/31/2020
7/31/2019
7/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments33,639 47,86560,14660,041
Cash and cash equivalents4,159 47,86560,14660,041
Short-term investments29,480    
Receivables15,316 9,14110,73813,147
Inventory, net of allowances, customer advances and progress billings13,851 7,7847,8427,278
Inventory13,851 7,7847,8427,278
Prepaid expense3,904 3,9752,7272,734
Total current assets:66,710 68,76581,45383,200
Noncurrent Assets
Operating lease, right-of-use asset15,407 19,916 
Property, plant and equipment17,527 14,48214,2547,636
Intangible assets, net (including goodwill)7,552 7,9908,4849,338
Goodwill7,452 7,4527,4527,452
Intangible assets, net (excluding goodwill)100 5381,0321,886
Other noncurrent assets1,626 1,3852,4491,486
Total noncurrent assets:42,112 43,77325,18718,460
TOTAL ASSETS:108,822 112,538106,640101,660
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22,725 21,33615,61819,570
Accounts payable6,860 8,5037,2569,516
Accrued liabilities15,865 12,8338,36210,054
Debt  7,000  
Other liabilities236 344391616
Other undisclosed current liabilities3,187 4,121  
Total current liabilities:26,148 32,80116,00920,186
Noncurrent Liabilities
Long-term debt and lease obligation17,469 21,1644,179 
Long-term debt, excluding current maturities4,270 4,4854,179 
Operating lease, liability13,199 16,679 
Liabilities, other than long-term debt79 192424353
Other liabilities79 192424353
Total noncurrent liabilities:17,548 21,3564,603353
Total liabilities:43,696 54,15720,61220,539
Stockholders' equity
Stockholders' equity attributable to parent65,126 58,38186,02881,121
Common stock485 479476472
Additional paid in capital338,021 334,473332,704330,770
Accumulated other comprehensive income1,971 1,6812,5802,100
Accumulated deficit(275,351) (278,252)(249,732)(252,221)
Total stockholders' equity:65,126 58,38186,02881,121
TOTAL LIABILITIES AND EQUITY:108,822 112,538106,640101,660

Income statement (P&L) ($ in thousands)

1/31/2022
TTM
7/31/2021
7/31/2020
7/31/2019
7/31/2018
Revenues(7,540) 76,02181,170104,713
Cost of revenue(48,111) (52,251)(60,080) 
Cost of goods and services sold(48,111) (52,251)(57,922) 
Gross profit:37,267 23,77021,090104,713
Operating expenses(44,604) (54,137)(19,357)(56,492)
Other undisclosed operating loss    (60,385)
Operating income (loss):(7,337) (30,367)1,733(12,164)
Nonoperating income5,476 1,393756746
Investment income, nonoperating   1,056853
Foreign currency transaction gain (loss), before tax(989) 905(682)(275)
Other nonoperating income6,465 488382168
Interest and debt expense(9) (35)  
Other undisclosed income from continuing operations before equity method investments, income taxes  489  
Income (loss) from continuing operations before equity method investments, income taxes:(1,870) (28,520)2,489(11,418)
Other undisclosed income from continuing operations before income taxes122    
Income (loss) from continuing operations before income taxes:(1,748) (28,520)2,489(11,418)
Income tax benefit    1,097
Income (loss) before gain (loss) on sale of properties:(1,748) (28,520)2,489(10,321)
Other undisclosed net income42    
Net income (loss) available to common stockholders, basic:(1,706) (28,520)2,489(10,321)
Other undisclosed net income available to common stockholders, diluted134    
Net income (loss) available to common stockholders, diluted:(1,572) (28,520)2,489(10,321)

Comprehensive Income ($ in thousands)

1/31/2022
TTM
7/31/2021
7/31/2020
7/31/2019
7/31/2018
Net income (loss):(1,706) (28,520)2,489(10,321)
Comprehensive income (loss):(1,706) (28,520)2,489(10,321)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent703 (899)48087
Comprehensive income (loss), net of tax, attributable to parent:(1,003) (29,419)2,969(10,234)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: